TRISHA HUTSON: Open Payments
NPI 1568701662 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,172 in 55 payments from 14 companies in 2025. Trend: 2023 $1,259 · 2024 $1,417 · 2025 $1,172
Food & beverage: $1,172
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $330 |
| AstraZeneca Pharmaceuticals LP | 12 | $300 |
| PFIZER INC. | 8 | $132 |
| ABBVIE INC. | 4 | $79 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $70 |
| Phathom Pharmaceuticals, Inc. | 2 | $42 |
| Corcept Therapeutics | 2 | $42 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $32 |
Products named: AIRSUPRA, Rybelsus, Ozempic, NURTEC ODT, XIFAXAN, BREZTRI, QULIPTA, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
